↓ Skip to main content

Cochrane Database of Systematic Reviews

PI3K/AKT/mTOR inhibitors for advanced or recurrent endometrial cancer

Overview of attention for article published in Cochrane database of systematic reviews, October 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (81st percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

policy
1 policy source
twitter
8 tweeters
facebook
1 Facebook page
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
55 Dimensions

Readers on

mendeley
125 Mendeley
Title
PI3K/AKT/mTOR inhibitors for advanced or recurrent endometrial cancer
Published in
Cochrane database of systematic reviews, October 2019
DOI 10.1002/14651858.cd012160.pub2
Pubmed ID
Authors

Felicia Roncolato, Kristina Lindemann, Melina L Willson, Julie Martyn, Linda Mileshkin

Twitter Demographics

The data shown below were collected from the profiles of 8 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 125 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 125 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 14 11%
Student > Master 13 10%
Researcher 7 6%
Student > Doctoral Student 7 6%
Student > Postgraduate 5 4%
Other 19 15%
Unknown 60 48%
Readers by discipline Count As %
Medicine and Dentistry 28 22%
Nursing and Health Professions 10 8%
Biochemistry, Genetics and Molecular Biology 6 5%
Unspecified 5 4%
Pharmacology, Toxicology and Pharmaceutical Science 4 3%
Other 10 8%
Unknown 62 50%

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 May 2022.
All research outputs
#2,980,266
of 23,166,665 outputs
Outputs from Cochrane database of systematic reviews
#5,681
of 12,383 outputs
Outputs of similar age
#64,578
of 351,741 outputs
Outputs of similar age from Cochrane database of systematic reviews
#107
of 192 outputs
Altmetric has tracked 23,166,665 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,383 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 32.5. This one has gotten more attention than average, scoring higher than 53% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 351,741 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 192 others from the same source and published within six weeks on either side of this one. This one is in the 44th percentile – i.e., 44% of its contemporaries scored the same or lower than it.